Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Jane Armitage, Professor of Clinical Trials and Epidemiology, was recognised in the New Year’s Honours list, published on 29 December. Jane was appointed Officer of the Order of the British Empire (OBE) in recognition of her services to medical research. 

The New Year’s Honours list recognises outstanding achievements by a wide range of extraordinary people from across the United Kingdom. People are awarded honours for achievements in their field of work (including health, education, science and technology), as well as for making a difference to their community.

Professor Armitage joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), now part of NDPH, in 1990. She has co-ordinated and been Principal Investigator of a number of our major randomised clinical trials in cardiovascular disease, including the MRC/BHF Heart Protection Study, SEARCH (Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine), HPS2-THRIVE (Treatment of HDL to Reduce the Incidence of Vascular Events) and ASCEND (A Study of Cardiovascular Events in Diabetes).

In addition to her work on clinical trials, Jane has undertaken valuable roles in the Department (for example, as its Director of Training & Career Development and as a programme leader for our MRC Population Health Research Unit), as well as acting as a member of a number of external Steering Committees and Grant Review Committees, and as an Honorary Consultant in Public Health Medicine.

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, said: “Jane is well-known and highly respected within the research community both nationally and internationally, and I’m absolutely delighted that her significant achievements have been recognised by this honour. Her OBE is very well-deserved, and it is a due recognition of her sustained contribution to improving the lives of those suffering from, or at risk of, cardiovascular disease.”

Professor Armitage is one of six members of the University of Oxford to be honoured this year.

Similar stories

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.

BHF Senior Fellowship renewal for Duncan Sparrow could pave the way to revealing unknown causes of heart defects in babies

Congratulations are in order for Associate Professor Duncan Sparrow, who has been awarded a renewal of his British Heart Foundation Senior Basic Science Research Fellowship. The award will fund crucial investigations into little understood environmental risk factors of congenital heart disease, and could one day lead to new therapeutic strategies.

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.

Study indicates reasons for decline in death rates from heart attacks

A new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.

Review highlights impact of Long COVID on cardiovascular system

The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID on the cardiovascular system.